Related Articles
Breast carcinomas expressing basal markers have poor clinical outcome regardless of estrogen receptor status
Establishment and characterization of seven human breast cancer cell lines including two triple-negative cell lines
Growth and molecular interactions of the anti-EGFR antibody Cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: New prospects in the treatment of triple-negative/basal-like breast cancer
Immunohistochemical profiling of node negative breast carcinomas allows prediction of metastatic risk
Prognostic value of periostin in early-stage breast cancer treated with conserving surgery and radiotherapy